Gaining Optimal Osteoporosis Assessments in Long-Term Care (GOAL)

NCT01887392 | Completed

• 1 other identifier: REB 13-229
• Study Type: interventional
• Target: 6,800
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to disseminate the 2010 Osteoporosis Canada clinical practice guidelines, using a multi-faceted Knowledge Translation (KT) model, as KT aims to close the gap between knowledge generated from research and practice. The investigators' primary objective is to evaluate if this intervention can increase the percent of long-term care (LTC) residents receiving appropriate treatment for osteoporosis (i.e. treatment is considered appropriate for an individual over age 50 who has had a diagnosis of osteoporosis or a fragility fracture of the hip or vertebrae and those who have had more than one fragility fracture and is therefore considered high-risk). A secondary objective is to examine whether the intervention increases the percent of all LTC residents receiving Vitamin D equivalent to ≥800 IU/day.

Conditions

Osteoporosis

Keywords

Long-term Care; Knowledge Translation

Outcome Measures

Primary Outcomes (1)

• Difference in the percentage of residents appropriately prescribed an osteoporosis medication before and after the intervention.

  Difference in the percentage of residents appropriately prescribed an osteoporosis medication before and after the intervention will be measured. Medications to be included in the baseline and post data download are in accordance with the current Osteoporosis Canada guidelines. Treatment is considered appropriate for an individual over age 50 who has had a diagnosis of osteoporosis or a fragility fracture of the hip or vertebra and those who have had more than one fragility fracture (i.e. high risk).

  18 months

Secondary Outcomes (1)

• Difference in the percentage of residents prescribed Vitamin D (equivalent to ≥800 IU/day) before and after the intervention.

  18 months

Study Arms (2)

Wave A

EXPERIMENTAL

LTC Homes randomized into Wave A will receive the intervention first. The intervention includes Knowledge Translation Education Sessions.

Other: Knowledge Translation Education Sessions

Wave B

EXPERIMENTAL

LTC Homes randomized into Wave B will receive the intervention after Wave A. The intervention includes Knowledge Translation Education Sessions.

Other: Knowledge Translation Education Sessions

Interventions

Knowledge Translation Education Sessions OTHER

Two interactive sessions will be delivered to the interprofessional team at Month 1 and Month 6 and are 1 hour in length. The Clinical Consultant Pharmacist at each LTC home will lead the Knowledge Translation Sessions. Participants will watch an educational video, developed by the co-investigators with expertise in osteoporosis and geriatrics and members of the Ontario College of Family Physicians. Accompanying materials that support the topics in the video will be provided. Following the educational video, one of the experts from the video will phone the LTC home to address questions and provide the home with direct access to an expert.

Wave A; Wave B

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• A minimum of 2 physicians for each LTC home served by a Pharmacy provider

You may not qualify if:

• LTC homes that have only one prescribing physician

Sponsors & Collaborators

• McMaster University: lead

Study Sites (1)

St. Peter's Hospital

Hamilton, Ontario, L8M 1W9, Canada

Location

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, Metabolic; Bone Diseases; Musculoskeletal Diseases; Metabolic Diseases; Nutritional and Metabolic Diseases

Study Officials

• Alexandra Papaioannou, MD, MSc

  McMaster University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Hamilton Health Sciences

Study Record Dates

• First Submitted: June 24, 2013
• First Posted: June 26, 2013
• Study Start: June 1, 2013
• Primary Completion: September 1, 2016
• Study Completion: September 1, 2016
• Last Updated: July 1, 2025

Record last verified: 2016-12

Locations

CA (1)